Quantitative analysis of desmethylselegiline, methamphetamine, and amphetamine in hair and plasma from Parkinson patients on long-term selegiline medication

Journal of Analytical Toxicology

Volumn 27, Issue 3, 2003, Pages 135-141

  Kronstrand, Robert ^a   Ahlner, Johan ^a   Dizdar, Nil ^a   Larson, Göran ^b  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; AMPHETAMINE; CHLORPROMAZINE; CODEINE; MELANIN; METHADONE; METHAMPHETAMINE; NORSELEGILINE; SELEGILINE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG HAIR LEVEL; FEMALE; GAS CHROMATOGRAPHY; HAIR ANALYSIS; HUMAN; MALE; MASS SPECTROMETRY; PARKINSON DISEASE; PATIENT COMPLIANCE; PIGMENTATION; QUANTITATIVE ANALYSIS; SPECTROPHOTOMETRY;

EID: 0037390774     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/27.3.135     Document Type: Article

References (23)

1. I. Mahmood. Clinical pharmacokinetics and pharmacodynamics of selegiline. Clin. Pharmacokinet. 33: 91-102 (1997).
2. R. Kronstrand, M. Choi-Andersson, J. Ahlner, and G. Larson. Incorporation of selegiline metabolites in hair after oral selegiline intake. J. Anal. Toxicol. 25: 594-601 (2001).
3. M.H. Slawson, D.G. Wilkins, and D.E. Rollins. The incorporation of drugs in hair: relationship of hair color and melanin concentration to phencyclidine incorporation. J. Anal. Toxicol. 22: 406-413 (1998).
4. R. Kronstrand, S. Förstberg-Peterson, B. Kågedal, J. Ahlner, and G. Larson. Codeine concentration in hair after oral administration is dependent on melanin content. Clin. Chem. 45: 1485-1494 (1999).
5. D.L. Hubbard, D.G. Wilkins, and D.E. Rollins. The incorporation of cocaine and metabolites into hair: effects of dose and hair pigmentation. Drug Metab. Dispos. 28: 1464-1469 (2000).
6. L. Pötsch, G. Skopp, and M.R. Moeller. Influence of pigmentation on the codeine content of hair fibers in guinea pigs. J. Forensic Sci. 42: 1095-1098 (1997).
7. S. Gygi, D.G. Wilkins, and R.E. Rollins. A comparison of phenobarbital and codeine incorporation into pigmented and nonpigmented rat hair. J. Pharm. Sci. 86: 209-214 (1997).
8. P.R. Stout, D.J. Claffey, and J.A. Ruth. Incorporation and retention of radiolabeled S-(+)- and R-(-)-methamphetamine and S-(+)and R-(-)-N-(n-butyl)-amphetamine in mouse hair after systemic administration. Drug Metab. Dispos. 28: 286-291 (2000).
9. C.R. Borges, D.G. Wilkins, and D.E. Rollins. Amphetamine and N-acetylamphetamine incorporation into hair: an investigation of the potential role of drug basicity in hair color bias. J. Anal. Toxicol. 25: 221-226 (2001).
10. S.J. Green and J.F. Wilson. The effect of hair color on the incorporation of methadone into hair in the rat. J. Anal. Toxicol. 20: 121-123 (1996).
11. R.W. Reid, F.L. O'Connor, A.G. Deakin, D.M. Ivery, and J.W. Crayton. Cocaine and metabolites in human graying hair: pigmentary relationship. Clin. Toxicol. 34: 685-690 (1996).
12. H. Sato, T. Uematsu, K. Yamada, and M. Nakashima. Chlorpromazine in human scalp hair as an index of dosage history: comparison with simultaneously measured haloperidol. Eur. J. Clin. Pharmacol. 44: 439-444 (1993).
13. M. Rothe, F. Pragst, S. Thor, and J. Hunger. Effect of pigmentation on the drug deposition in hair of gray-haired subjects. Forensic Sci. Int. 84: 53-60 (1997).
14. J. Williams. The assessment of therapeutic compliance based upon the analysis of drug concentrations in hair. In Drug Testing Technology, T. Mieczkowski, Ed. CRC Press, Boca Raton, FL, 1999, pp 1-32.
15. P. Kintz. Clinical applications of hair analysis. In Drug Testing in Hair, P. Kintz, Ed. CRC Press, Boca Raton, FL, 1996, pp 267-277.
16. T. Uematsu, R. Sato, K. Suzuki, S. Yamaguchi, and M. Nakashima. Human scalp hair evidence of individual dosage history of haloperidol: method and retrospective study. Eur. J. Clin. Pharmacol. 37: 239-244 (1989).
17. H. Sato, T. Uematsu, R. Sato, S. Yamaguchi, and M. Nakashima. Human scalp hair as evidence of individual dosage history of haloperidol: prospective study. Ther. Drug Monit. 11: 686-691 (1989).
18. J.H. Beumer, I.J. Bosman, and R.A. Maes. Hair as a biological specimen for therapeutic drug monitoring. Int. J. Clin. Pract. 55: 353-357 (2001).
19. R. Kikura and Y. Nakahara. Hair analysis for drugs of abuse. IX. Comparison of deprenyl use and methamphetamine use by hair analysis. Biol. Pharm. Bull. 18: 267-272 (1995).
20. Y. Nakahara, M. Shimamine, and K. Takahashi. Hair analysis for drugs of abuse. III. Movement and stability of methoxyphenamine (as a model compound for methamphetamine) along hair shaft with hair growth. J. Anal. Toxicol. 16: 253-257 (1992).
21. G. Cooper, D.L. Allen, K.S. Scott, J.S. Oliver, J. Ditton, and I.D. Smith. Hair analysis: self reported use of "speed" and "ecstasy" compared with laboratory findings. J. Forensic Sci. 45: 400-406 (2000).
22. S. Suzuki, T. Inoue, H. Hori, and S. Iniyama. Analysis of methamphetamine in hair, nail, sweat, and saliva by mass fragmentography. J. Anal. Toxicol. 13: 176-178 (1989).
23. Y. Nakahara. Detection and diagnostic interpretation of amphetamines in hair. Forensic Sci. Int. 70: 135-153 (1995).